Straumann reported October 28 that third-quarter revenue increased 10.8% in Swiss francs to 667.1 million francs. Organic growth reached 9.2%, while revenue for the first nine months rose 4.9% as reported to 2.0465 billion francs.
The dental-products company said all regions contributed to quarterly growth. North American revenue reached 174.9 million francs, with organic growth of 7.5%, despite cautious consumer sentiment and broadly stable patient flow.
Europe, the Middle East and Africa generated 256 million francs, up 10.5% organically. Asia Pacific revenue rose 10.3% organically to 165.6 million francs, while Latin America grew 6.5% to 70.5 million francs.
Straumann said China returned to growth, although rules for the next round of dental-implant volume-based procurement had not yet been announced. It anticipated implementation in the first quarter of 2027.
The company retained its full-year forecast for high single-digit organic revenue growth and core operating-margin expansion of about 1.4–1.7 percentage points at constant 2025 exchange rates.
Source: Straumann Holding, October 28 results announcement through EQS.